Trends in prescription drug use among adults in the United States from 1999-2012

JAMA - Journal of the American Medical Association

Volumn 314, Issue 17, 2015, Pages 1818-1831

  Kantor, Elizabeth D ^a,b   Rehm, Colin D ^c,d   Haas, Jennifer S ^a,e   Chan, Andrew T ^e,f   Giovannucci, Edward L ^a,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c TUFTS UNIVERSITY   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AGENTS ACTING ON THE EYE; ANGIOTENSIN II ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIGLAUCOMA AGENT; ANTIGOUT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; ANTIVERTIGO AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; DERMATOLOGICAL AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOTRIENE DERIVATIVE; LOOP DIURETIC AGENT; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; STEROID 5ALPHA REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; PRESCRIPTION DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; DRUG USE; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH CARE SURVEY; HEALTH INSURANCE; HUMAN; MALE; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UNITED STATES; AGED; MIDDLE AGED; NUTRITION; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; ANTIDEPRESSIVE AGENTS; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; NUTRITION SURVEYS; POLYPHARMACY; PRESCRIPTION DRUGS; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84946081910     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.13766     Document Type: Article

References (41)

1. Schumock GT, Li EC, Suda KJ, et al. National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm. 2014; 71(6):482-499.
2. Gu Q, D illon CF, Burt VL. Prescription drug use continues to increase: US prescription drug data for 2007-2008. NCHS Data Brief. 2010;42(42):1-8.
3. Stagnitti MN. Medical Expenditure Panel Survey webs ite. Statistical brief 180: the top five outpatient prescription drugs ranked by total expense for children, adults, and the elderly, 2004. http://www.meps.ahrq.gov/mepsweb/data-files/publications/st180/stat180.pdf. 2007. Accessed March 29, 2015.
4. Thielke SM, Simoni-Wastila L, Edlund MJ, et al. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med. 2010;11(2):248-256.
5. Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37(2):343-349.
6. Chong Y, Fryer CD, Gu Q. Prescription sleep aid use among adults: United States, 2005-2010. NCHS Data Brief. 2013;127(127):1-8.
7. Ford ES, Mannino DM, Wheaton AG, et al. Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010. PLoS One. 2014;9 (4):e95305.
8. Gu Q, Paulose-RamR, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006;113(2):213-221.
9. Gu Q, Paulose-RamR, Burt VL, Kit BK. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012. NCHS Data Brief. 2014;177(177):1-8.
10. Jewett PI, Gangnon RE, Trentham-Dietz A, Sprague BL. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol. 2014;124 (4):727-733.
11. Ka ufman DW, Kelly JP, Rosenberg L, Anderson TE,Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337-344.
12. Paulose-RamR, Jonas BS, Orwig D, SafranMA. Prescription psychotropic medication use among the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol. 2004;57(3):309-317.
13. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867-2878.
14. Yoon SS, Gu Q, Nwankwo T,Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 201 2. Hypertension. 2015;65(1):54-61.
15. National Center for Health Statistics. Health, United States, 2013:With Special Feature on Prescription Drugs. Hyattsville, MD: Centers for Disease Control and Prevention; 2014.
16. National Center for Health Statistics. NHANES 2003-2004 Public Data General Release File Documentation. http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/general-data-release-doc-03-04.pdf.Accessed March 28, 2015.
17. National Health and Nutrition Examination Survey. Continuous NHANES. http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes-continuous.aspx. Accessed September 15 2015
18. National Health and Nutrition Examination Survey. Continuous NHANES. http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes-continuous.aspx. Accessed September 15, 2015. 18. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187-19 5.
19. Johnson CL, Paulose-RamR, Ogden CL, et al National health and nutrition examination survey: analytic guidelines, 1999-2010. Vital Health Stat 2. 2013;(161):1-24.
20. Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29): 3670-3682.
21. Kim HJ, Fay MP, Feuer E J,Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3): 335-351.
22. National Center for Health Statistics. NHANES Response Rates and Population Totals. http://www .cdc.gov/nchs/nhanes/response-rates-cps.htm. Accessed March 28, 2015.
23. Klein RJ, Proctor SE, BoudreaultMA, Turczyn KM. Healthy People 2010 criteria for data suppression. Healthy People 2010 Stat Notes. 2002;(24):1-12.
24. Chobanian AV, Bakris GL , Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh R eport of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19): 2560-2572.
25. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
26. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiov a scular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2014;63(25 pt B):2889-2934.
27. Blumner KH, Marcus SC. Changing perceptions of depression: ten-year trends from the general social survey. Psychiatr Serv. 2009;60(3):306-312.
28. Goodnick PJ, Goldstein BJ. Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology. J Psychopharmacol. 1998;12(3) (suppl B):S5-S20.
29. Ross JS, Madigan D, Hill KP, Egilman DS,Wang Y, Krumholz HM. Pooled analysis of rofecoxib pl acebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Intern Med. 2009;169(21):1976-1985.
30. Manchikanti L, Helm S II, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3)(suppl):ES9-ES38.
31. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for theWomen's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from theWomen's Health Initiative randomized controlled trial. JAMA. 2002;288(3): 321-333.
32. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160(8):517-525.
33. Bennett WL,Wilson LM, Bolen S, et al. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update. Comparative Effectiveness Review No. AHRQ Publication No. 11-EHC038-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2011. http://www.effectivehealthcare .ahrq.gov/reports/final.cfm. Accessed July 24, 2015.
34. Nissen SE,Wolski K. Effect of rosiglitazone on the risk ofmyocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24): 2457-2471.
35. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-681.
36. Kornfield R, Donohue J, Berndt ER, Alexander GC. Promotion of prescription drugs to consumers and providers, 2001-2010. PLoS One. 2013;8(3):e55504.
37. Daubresse M, Hutfless S, Kim Y, et al. Effect of direct-to-consumer advertising on asthma medication sales and healthcare use. Am J Respir Crit Ca re Med. 2015;192(1):40-46.
38. Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. The DAWN Report: ED Visits Involving the Muscle Relaxant Carisoprodol.http://oas.samhsa.gov/2k11/DAWN071/WEB-DAWN-071-HTML.pdf. Accessed July 25 2015.
39. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354(22):2340-2348.
40. Perez AD, Hirschman C. The changing racial and ethnic composition of the US population: emerging american identities. Popul Dev Rev. 2009;35(1):1-51.
41. Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA. 1993;270(20):2464-2468.